{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:33:22Z","timestamp":1772120002235,"version":"3.50.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"NIH","award":["R00AG065645"],"award-info":[{"award-number":["R00AG065645"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s12035-025-05130-x","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T23:04:40Z","timestamp":1750287880000},"page":"13479-13499","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["MicroRNA-502-3p Modulates the GABA A Subunits, Synaptic Proteins, and Mitochondrial Morphology in Hippocampal Neurons"],"prefix":"10.1007","volume":"62","author":[{"given":"Bhupender","family":"Sharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Rodarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunjan","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheryl","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subodh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,19]]},"reference":[{"key":"5130_CR1","doi-asserted-by":"publisher","unstructured":"Kumar S, Reddy PH (2016) Are circulating microRNAs peripheral biomarkers for Alzheimer\u2019s disease. Biochim Biophys Acta - Mol Basis Dis 1862(9):1617\u20131627. https:\/\/doi.org\/10.1016\/j.bbadis.2016.06.001","DOI":"10.1016\/j.bbadis.2016.06.001"},{"issue":"146","key":"5130_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/bs.pmbts.2016.12.013","volume":"1","author":"S Kumar","year":"2017","unstructured":"Kumar S, Vijayan M, Bhatti JS, Reddy PH (2017) MicroRNAs as peripheral biomarkers in aging and age-related diseases. Prog Mol Biol Transl Sci 1(146):47\u201394. https:\/\/doi.org\/10.1016\/bs.pmbts.2016.12.013","journal-title":"Prog Mol Biol Transl Sci"},{"key":"5130_CR3","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/bs.pmbts.2016.12.009","volume":"146","author":"PH Reddy","year":"2017","unstructured":"Reddy PH, Williams J, Smith F, Bhatti JS, Kumar S, Vijayan M, Kandimalla R, Kuruva CS et al (2017) MicroRNAs, aging, cellular senescence, and Alzheimer\u2019s disease. Prog Mol Biol Transl Sci 146:127\u2013171. https:\/\/doi.org\/10.1016\/bs.pmbts.2016.12.009","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"12","key":"5130_CR4","doi-asserted-by":"publisher","first-page":"165937","DOI":"10.1016\/j.bbadis.2020.165937","volume":"866","author":"S Kumar","year":"2020","unstructured":"Kumar S, Reddy PH (2020) The role of synaptic microRNAs in Alzheimer\u2019s disease. Biochimica et Biophysica Acta (BBA)-Mol Basis Dis 866(12):165937. https:\/\/doi.org\/10.1016\/j.bbadis.2020.165937","journal-title":"Biochimica et Biophysica Acta (BBA)-Mol Basis Dis"},{"key":"5130_CR5","doi-asserted-by":"publisher","first-page":"102123","DOI":"10.1016\/j.arr.2023.10","volume":"13","author":"J Rivera","year":"2023","unstructured":"Rivera J, Sharma B, Torres MM, Kumar S (2023) Factors affecting the GABAergic synapse function in Alzheimer\u2019s disease: focus on microRNAs. Ageing Res Rev 13:102123. https:\/\/doi.org\/10.1016\/j.arr.2023.10","journal-title":"Ageing Res Rev"},{"issue":"3","key":"5130_CR6","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00401-022-02526-0","volume":"145","author":"P Scaduto","year":"2023","unstructured":"Scaduto P, Lauterborn JC, Cox CD, Fracassi A, Zeppillo T, Gutierrez BA, Keene CD, Crane PK et al (2023) Functional excitatory to inhibitory synaptic imbalance and loss of cognitive performance in people with Alzheimer\u2019s disease neuropathologic change. Acta Neuropathol 145(3):303\u2013324. https:\/\/doi.org\/10.1007\/s00401-022-02526-0","journal-title":"Acta Neuropathol"},{"key":"5130_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-015-0013-z","volume":"10","author":"M Marttinen","year":"2015","unstructured":"Marttinen M, Kurkinen KM, Soininen H, Haapasalo A, Hiltunen M (2015) Synaptic dysfunction and septin protein family members in neurodegenerative diseases. Mol Neurodegener 10:1\u20132. https:\/\/doi.org\/10.1186\/s13024-015-0013-z","journal-title":"Mol Neurodegener"},{"issue":"1","key":"5130_CR8","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41386-022-01370-w","volume":"48","author":"LG Appelbaum","year":"2023","unstructured":"Appelbaum LG, Shenasa MA, Stolz L, Daskalakis Z (2023) Synaptic plasticity and mental health: methods, challenges and opportunities.\u00a0Neuropsychopharmacol\u00a048(1):113\u2013120. https:\/\/doi.org\/10.1038\/s41386-022-01370-w","journal-title":"Neuropsychopharmacology"},{"key":"5130_CR9","doi-asserted-by":"publisher","unstructured":"Nilsson J, Pichet Binette A, Palmqvist S, Brum WS, Janelidze S, Ashton NJ, Spotorno N, Stomrud E et al (2024) Cerebrospinal fluid biomarker panel for synaptic dysfunction in a broad spectrum of neurodegenerative diseases. Brain 7. https:\/\/doi.org\/10.1093\/brain\/awae032","DOI":"10.1093\/brain\/awae032"},{"key":"5130_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-1326-4-48","volume":"4","author":"GM Shankar","year":"2009","unstructured":"Shankar GM, Walsh DM (2009) Alzheimer\u2019s disease: synaptic dysfunction and A\u03b2. Mol Neurodegener 4:1\u20133. https:\/\/doi.org\/10.1186\/1750-1326-4-48","journal-title":"Mol Neurodegener"},{"issue":"Suppl 2","key":"5130_CR11","doi-asserted-by":"publisher","first-page":"S499","DOI":"10.3233\/JAD-2010-100504","volume":"20 Suppl 2","author":"PH Reddy","year":"2010","unstructured":"Reddy PH, Manczak M, Mao P, Calkins MJ, Reddy AP, Shirendeb U (2010) Amyloid-beta and mitochondria in aging and Alzheimer\u2019s disease: implications for synaptic damage and cognitive decline. J Alzheimers Dis 20 Suppl 2(Suppl 2):S499\u2013512. https:\/\/doi.org\/10.3233\/JAD-2010-100504","journal-title":"J Alzheimers Dis"},{"issue":"9","key":"5130_CR12","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1111\/jnc.16183","volume":"168","author":"TA Strope","year":"2024","unstructured":"Strope TA, Wilkins HM (2024) The reciprocal relationship between amyloid precursor protein and mitochondrial function. J Neurochem 168(9):2275\u20132284. https:\/\/doi.org\/10.1111\/jnc.16183","journal-title":"J Neurochem"},{"issue":"4","key":"5130_CR13","doi-asserted-by":"publisher","first-page":"969","DOI":"10.3233\/JAD-170256","volume":"57","author":"PH Reddy","year":"2017","unstructured":"Reddy PH (2017) A critical assessment of research on neurotransmitters in Alzheimer\u2019s disease. J Alzheimers Dis 57(4):969\u2013974. https:\/\/doi.org\/10.3233\/JAD-170256","journal-title":"J Alzheimers Dis"},{"issue":"184","key":"5130_CR14","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/B978-0-12-819410-2.00022-9","volume":"1","author":"S Pelucchi","year":"2022","unstructured":"Pelucchi S, Gardoni F, Di Luca M, Marcello E (2022) Synaptic dysfunction in early phases of Alzheimer\u2019s disease. Handb Clin Neurol 1(184):417\u2013438. https:\/\/doi.org\/10.1016\/B978-0-12-819410-2.00022-9","journal-title":"Handb Clin Neurol"},{"issue":"7","key":"5130_CR15","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1038\/s41380-022-01565-z","volume":"27","author":"L Peng","year":"2022","unstructured":"Peng L, Bestard-Lorigados I, Song W (2022) The synapse as a treatment avenue for Alzheimer\u2019s disease. Mol Psychiatry 27(7):2940\u20132949. https:\/\/doi.org\/10.1038\/s41380-022-01565-z","journal-title":"Mol Psychiatry"},{"issue":"1","key":"5130_CR16","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41525-022-00319-8","volume":"7","author":"S Kumar","year":"2022","unstructured":"Kumar S, Orlov E, Gowda P, Bose C, Swerdlow RH, Lahiri DK, Reddy PH (2022) Synaptosome microRNAs regulate synapse functions in Alzheimer\u2019s disease. NPJ Genom Med 7(1):47. https:\/\/doi.org\/10.1038\/s41525-022-00319-8","journal-title":"NPJ Genom Med"},{"issue":"6","key":"5130_CR17","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.4103\/1673-5374.360172","volume":"18","author":"S Kumar","year":"2023","unstructured":"Kumar S (2023) Synaptosome microRNAs: emerging synapse players in aging and Alzheimer\u2019s disease. Neural Regen Res 18(6):1275\u20131276. https:\/\/doi.org\/10.4103\/1673-5374.360172","journal-title":"Neural Regen Res"},{"issue":"4","key":"5130_CR18","doi-asserted-by":"publisher","first-page":"532","DOI":"10.3390\/ph16040532","volume":"16","author":"D Devara","year":"2023","unstructured":"Devara D, Choudhary Y, Kumar S (2023) Role of microRNA-502-3p in human diseases. Pharmaceuticals 16(4):532. https:\/\/doi.org\/10.3390\/ph16040532","journal-title":"Pharmaceuticals"},{"issue":"12","key":"5130_CR19","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.4103\/NRR.NRR-D-23-01064","volume":"19","author":"B Sharma","year":"2024","unstructured":"Sharma B, Torres MM, Rodriguez S, Gangwani L, Kumar S (2024) MicroRNA-502-3p regulates GABAergic synapse function in hippocampal neurons. Neural Regen Res 19(12):2698\u20132707. https:\/\/doi.org\/10.4103\/NRR.NRR-D-23-01064","journal-title":"Neural Regen Res"},{"issue":"9","key":"5130_CR20","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1016\/j.bbadis.2019.06.006","volume":"1865","author":"S Kumar","year":"2019","unstructured":"Kumar S, Reddy AP, Yin X, Reddy PH (2019) Novel MicroRNA-455-3p and its protective effects against abnormal APP processing and amyloid beta toxicity in Alzheimer\u2019s disease. Biochim Biophys Acta Mol Basis Dis 1865(9):2428\u20132440. https:\/\/doi.org\/10.1016\/j.bbadis.2019.06.006","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"6","key":"5130_CR21","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.3390\/jcm9061783","volume":"9","author":"A De Gaetano","year":"2020","unstructured":"De Gaetano A, Gibellini L, Bianchini E, Borella R, De Biasi S, Nasi M, Boraldi F, Cossarizza A et al (2020) Impaired mitochondrial morphology and functionality in Lonp1wt\/- mice. J Clin Med 9(6):1783. https:\/\/doi.org\/10.3390\/jcm9061783","journal-title":"J Clin Med"},{"issue":"19","key":"5130_CR22","doi-asserted-by":"publisher","first-page":"3808","DOI":"10.1093\/hmg\/ddx267","volume":"26","author":"S Kumar","year":"2017","unstructured":"Kumar S, Vijayan M, Reddy PH (2017) MicroRNA-455-3p as a potential peripheral biomarker for Alzheimer\u2019s disease. Hum Mol Genet 26(19):3808\u20133822. https:\/\/doi.org\/10.1093\/hmg\/ddx267","journal-title":"Hum Mol Genet"},{"issue":"5","key":"5130_CR23","doi-asserted-by":"publisher","first-page":"5451","DOI":"10.1002\/jcp.27486","volume":"234","author":"K Saliminejad","year":"2019","unstructured":"Saliminejad K, Khorram Khorshid HR, Soleymani Fard S, Ghaffari SH (2019) An overview of microRNAs: biology, functions, therapeutics, and analysis methods. J Cell Physiol 234(5):5451\u20135465. https:\/\/doi.org\/10.1002\/jcp.27486","journal-title":"J Cell Physiol"},{"issue":"6","key":"5130_CR24","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.tig.2022.02.006","volume":"38","author":"C Diener","year":"2022","unstructured":"Diener C, Keller A, Meese E (2022) Emerging concepts of miRNA therapeutics: from cells to clinic. Trends Genet 38(6):613\u2013626. https:\/\/doi.org\/10.1016\/j.tig.2022.02.006","journal-title":"Trends Genet"},{"issue":"3","key":"5130_CR25","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrd.2016.246","volume":"16","author":"R Rupaimoole","year":"2017","unstructured":"Rupaimoole R, Slack FJ (2017) MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov 16(3):203\u2013222. https:\/\/doi.org\/10.1038\/nrd.2016.246","journal-title":"Nat Rev Drug Discov"},{"issue":"Suppl 1","key":"5130_CR26","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1186\/1471-2202-7-S1-S4","volume":"7 Suppl 1","author":"G Brachya","year":"2006","unstructured":"Brachya G, Yanay C, Linial M (2006) Synaptic proteins as multi-sensor devices of neurotransmission. BMC Neurosci 7 Suppl 1(Suppl 1):S4. https:\/\/doi.org\/10.1186\/1471-2202-7-S1-S4","journal-title":"BMC Neurosci"},{"issue":"2","key":"5130_CR27","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/jnc.12245","volume":"126","author":"C Chung","year":"2013","unstructured":"Chung C, Raingo J (2013) Vesicle dynamics: how synaptic proteins regulate different modes of neurotransmission. J Neurochem 126(2):146\u2013154. https:\/\/doi.org\/10.1111\/jnc.12245","journal-title":"J Neurochem"},{"issue":"11","key":"5130_CR28","doi-asserted-by":"publisher","first-page":"5954","DOI":"10.3390\/ijms23115954","volume":"23","author":"RI Teleanu","year":"2022","unstructured":"Teleanu RI, Niculescu AG, Roza E, Vlad\u00e2cenco O, Grumezescu AM, Teleanu DM (2022) Neurotransmitters-key factors in neurological and neurodegenerative disorders of the central nervous system. Int J Mol Sci 23(11):5954. https:\/\/doi.org\/10.3390\/ijms23115954","journal-title":"Int J Mol Sci"},{"key":"5130_CR29","doi-asserted-by":"publisher","first-page":"101994","DOI":"10.1016\/j.arr.2023.101994","volume":"89","author":"M Nimgampalle","year":"2023","unstructured":"Nimgampalle M, Chakravarthy H, Sharma S, Shree S, Bhat AR, Pradeepkiran JA, Devanathan V (2023) Neurotransmitter systems in the etiology of major neurological disorders: emerging insights and therapeutic implications. Ageing Res Rev 89:101994. https:\/\/doi.org\/10.1016\/j.arr.2023.101994","journal-title":"Ageing Res Rev"},{"issue":"172","key":"5130_CR30","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.freeradbiomed.2021.07.013","volume":"20","author":"H Morton","year":"2021","unstructured":"Morton H, Kshirsagar S, Orlov E, Bunquin LE, Sawant N, Boleng L, George M, Basu T et al (2021) Defective mitophagy and synaptic degeneration in Alzheimer\u2019s disease: focus on aging, mitochondria and synapse. Free Radic Biol Med 20(172):652\u2013667. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2021.07.013","journal-title":"Free Radic Biol Med"},{"key":"5130_CR31","doi-asserted-by":"publisher","first-page":"101529","DOI":"10.1016\/j.arr.2021.101529","volume":"73","author":"P Gowda","year":"2022","unstructured":"Gowda P, Reddy PH, Kumar S (2022) Deregulated mitochondrial microRNAs in Alzheimer\u2019s disease: focus on synapse and mitochondria. Ageing Res Rev 73:101529. https:\/\/doi.org\/10.1016\/j.arr.2021.101529","journal-title":"Ageing Res Rev"},{"issue":"9","key":"5130_CR32","doi-asserted-by":"publisher","first-page":"716209","DOI":"10.3389\/fcell.2021.716209","volume":"5","author":"L Chen","year":"2021","unstructured":"Chen L, Huang Y, Duan Z, Huang P, Yao H, Zhou Y, Ji Q, Liu X (2021) Exosomal miR-500 derived from lipopolysaccharide-treated macrophage accelerates liver fibrosis by suppressing MFN2. Front Cell Dev Biol 5(9):716209. https:\/\/doi.org\/10.3389\/fcell.2021.716209","journal-title":"Front Cell Dev Biol"},{"issue":"5","key":"5130_CR33","doi-asserted-by":"publisher","first-page":"e20655","DOI":"10.1371\/journal.pone.0020655","volume":"6","author":"P Huang","year":"2011","unstructured":"Huang P, Galloway CA, Yoon Y (2011) Control of mitochondrial morphology through differential interactions of mitochondrial fusion and fission proteins. PLoS ONE 6(5):e20655. https:\/\/doi.org\/10.1371\/journal.pone.0020655","journal-title":"PLoS ONE"},{"issue":"3","key":"5130_CR34","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.brainresrev.2005.03.004","volume":"49","author":"PH Reddy","year":"2005","unstructured":"Reddy PH, Beal MF (2005) Are mitochondria critical in the pathogenesis of Alzheimer\u2019s disease? Brain Res Brain Res Rev 49(3):618\u2013632. https:\/\/doi.org\/10.1016\/j.brainresrev.2005.03.004","journal-title":"Brain Res Brain Res Rev"},{"issue":"3","key":"5130_CR35","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1124\/jpet.112.192138","volume":"342","author":"A Johri","year":"2012","unstructured":"Johri A, Beal MF (2012) Mitochondrial dysfunction in neurodegenerative diseases. J Pharmacol Exp Ther 342(3):619\u2013630. https:\/\/doi.org\/10.1124\/jpet.112.192138","journal-title":"J Pharmacol Exp Ther"},{"issue":"7","key":"5130_CR36","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1111\/cns.13116","volume":"25","author":"Y Wang","year":"2019","unstructured":"Wang Y, Xu E, Musich PR, Lin F (2019) Mitochondrial dysfunction in neurodegenerative diseases and the potential countermeasure. CNS Neurosci Ther 25(7):816\u2013824. https:\/\/doi.org\/10.1111\/cns.13116","journal-title":"CNS Neurosci Ther"},{"key":"5130_CR37","doi-asserted-by":"publisher","first-page":"109485","DOI":"10.1016\/j.intimp.2022.109485","volume":"114","author":"W Jiang","year":"2023","unstructured":"Jiang W, Zhang Y, Sheng Y, Liu M, Du C, Pan X, Huang C, Li J et al (2023) Overexpression of IFIT1 protects against LPS-induced acute lung injury via regulating CCL5-p65NF-\u03baB signaling. Int Immunopharmacol 114:109485. https:\/\/doi.org\/10.1016\/j.intimp.2022.109485","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"5130_CR38","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3390\/v13010091","volume":"13","author":"V Schultz","year":"2021","unstructured":"Schultz V, Cumberworth SL, Gu Q, Johnson N, Donald CL, McCanney GA, Barrie JA, Da Silva FA et al (2021) Zika virus infection leads to demyelination and axonal injury in mature CNS cultures. Viruses 13(1):91. https:\/\/doi.org\/10.3390\/v13010091","journal-title":"Viruses"},{"issue":"1","key":"5130_CR39","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.celrep.2018.09.002","volume":"25","author":"SP John","year":"2018","unstructured":"John SP, Sun J, Carlson RJ, Cao B, Bradfield CJ, Song J, Smelkinson M, Fraser IDC (2018) IFIT1 exerts opposing regulatory effects on the inflammatory and interferon gene programs in LPS-activated human macrophages. Cell Rep 25(1):95\u2013106.e6. https:\/\/doi.org\/10.1016\/j.celrep.2018.09.002","journal-title":"Cell Rep"},{"issue":"1","key":"5130_CR40","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13287-020-1557-6","volume":"11","author":"YS Basmaeil","year":"2020","unstructured":"Basmaeil YS, Algudiri D, Alenzi R, Al Subayyil A, Alaiya A, Khatlani T (2020) HMOX1 is partly responsible for phenotypic and functional abnormalities in mesenchymal stem cells\/stromal cells from placenta of preeclampsia (PE) patients. Stem Cell Res Ther 11(1):30. https:\/\/doi.org\/10.1186\/s13287-020-1557-6","journal-title":"Stem Cell Res Ther"},{"issue":"5","key":"5130_CR41","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.3390\/cells9051275","volume":"9","author":"SY Park","year":"2020","unstructured":"Park SY, Kang JY, Lee T, Nam D, Jeon CJ, Kim JB (2020) SPON1 can reduce amyloid beta and reverse cognitive impairment and memory dysfunction in Alzheimer\u2019s disease mouse model. Cells 9(5):1275. https:\/\/doi.org\/10.3390\/cells9051275","journal-title":"Cells"},{"issue":"1","key":"5130_CR42","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3233\/ADR-200246","volume":"5","author":"S Fernandez","year":"2021","unstructured":"Fernandez S, Burnham SC, Milicic L, Savage G, Maruff P, Peretti M, Sohrabi HR, Lim YY et al (2021) SPON1 is associated with amyloid-\u03b2 and APOE \u03b54-related cognitive decline in cognitively normal adults. J Alzheimers Dis Rep 5(1):111\u2013120. https:\/\/doi.org\/10.3233\/ADR-200246","journal-title":"J Alzheimers Dis Rep"},{"issue":"2","key":"5130_CR43","doi-asserted-by":"publisher","first-page":"85","DOI":"10.59566\/IJBS.2014.10085","volume":"10","author":"GR de Lores Arnaiz","year":"2014","unstructured":"de Lores Arnaiz GR, Ordieres MG (2014) Brain Na(+), K(+)-ATPase activity in aging and disease. Int J Biomed Sci 10(2):85\u2013102","journal-title":"Int J Biomed Sci"},{"issue":"6","key":"5130_CR44","doi-asserted-by":"publisher","first-page":"27738","DOI":"10.1038\/srep27738","volume":"14","author":"IY Petrushanko","year":"2016","unstructured":"Petrushanko IY, Mitkevich VA, Anashkina AA, Adzhubei AA, Burnysheva KM, Lakunina VA, Kamanina YV, Dergousova EA et al (2016) Direct interaction of beta-amyloid with Na, K-ATPase as a putative regulator of the enzyme function. Sci Rep 14(6):27738. https:\/\/doi.org\/10.1038\/srep27738","journal-title":"Sci Rep"},{"issue":"5","key":"5130_CR45","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.pneurobio.2004.06.002","volume":"73","author":"JJ Haddad","year":"2004","unstructured":"Haddad JJ (2004) Mitogen-activated protein kinases and the evolution of Alzheimer\u2019s: a revolutionary neurogenetic axis for therapeutic intervention? Prog Neurobiol 73(5):359\u2013377. https:\/\/doi.org\/10.1016\/j.pneurobio.2004.06.002","journal-title":"Prog Neurobiol"},{"issue":"8","key":"5130_CR46","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.3390\/ijms19082260","volume":"19","author":"M Nitti","year":"2018","unstructured":"Nitti M, Piras S, Brondolo L, Marinari UM, Pronzato MA, Furfaro AL (2018) Heme oxygenase 1 in the nervous system: does it favor neuronal cell survival or induce neurodegeneration? Int J Mol Sci 19(8):2260. https:\/\/doi.org\/10.3390\/ijms19082260","journal-title":"Int J Mol Sci"},{"issue":"3","key":"5130_CR47","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.bcmd.2007.06.014","volume":"39","author":"J Truksa","year":"2007","unstructured":"Truksa J, Lee P, Beutler E (2007) The role of STAT, AP-1, E-box and TIEG motifs in the regulation of hepcidin by IL-6 and BMP-9: lessons from human HAMP and murine Hamp1 and Hamp2 gene promoters. Blood Cells Mol Dis 39(3):255\u2013262. https:\/\/doi.org\/10.1016\/j.bcmd.2007.06.014","journal-title":"Blood Cells Mol Dis"},{"issue":"1","key":"5130_CR48","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41420-020-00346-3","volume":"6","author":"X Zhang","year":"2020","unstructured":"Zhang X, Gou YJ, Zhang Y, Li J, Han K, Xu Y, Li H, You LH et al (2020) Hepcidin overexpression in astrocytes alters brain iron metabolism and protects against amyloid-\u03b2 induced brain damage in mice. Cell Death Discovery 6(1):113. https:\/\/doi.org\/10.1038\/s41420-020-00346-3","journal-title":"Cell Death Discovery"},{"key":"5130_CR49","doi-asserted-by":"publisher","first-page":"11553","DOI":"10.1038\/s41598-018-29770-3","volume":"8","author":"P Youssef","year":"2018","unstructured":"Youssef P, Chami B, Lim J et al (2018) Evidence supporting oxidative stress in a moderately affected area of the brain in Alzheimer\u2019s disease. Sci Rep 8:11553. https:\/\/doi.org\/10.1038\/s41598-018-29770-3","journal-title":"Sci Rep"},{"issue":"3","key":"5130_CR50","doi-asserted-by":"publisher","first-page":"613","DOI":"10.4103\/NRR.NRR-D-23-01343","volume":"20","author":"Y Shen","year":"2025","unstructured":"Shen Y, Zhang G, Wei C, Zhao P, Wang Y, Li M, Sun L (2025) Potential role and therapeutic implications of glutathione peroxidase 4 in the treatment of Alzheimer\u2019s disease. Neural Regen Res 20(3):613\u2013631. https:\/\/doi.org\/10.4103\/NRR.NRR-D-23-01343","journal-title":"Neural Regen Res"},{"issue":"316","key":"5130_CR51","doi-asserted-by":"publisher","first-page":"123011","DOI":"10.1016\/j.biomaterials.2024.123011","volume":"1","author":"Z Dai","year":"2025","unstructured":"Dai Z, Yu Y, Chen R, Zhu H, Fong H, Kuang J, Jiang Y, Chen Y et al (2025) Selenium promotes neural development through the regulation of GPX4 and SEPP1 in an iPSC-derived neuronal model. Biomater 1(316):123011. https:\/\/doi.org\/10.1016\/j.biomaterials.2024.123011","journal-title":"Biomaterials"},{"key":"5130_CR52","doi-asserted-by":"publisher","first-page":"6431","DOI":"10.1038\/s41598-018-24741-0","volume":"8","author":"A Van der Jeugd","year":"2018","unstructured":"Van der Jeugd A, Parra-Damas A, Baeta-Corral R et al (2018) Reversal of memory and neuropsychiatric symptoms and reduced tau pathology by selenium in 3xTg-AD mice. Sci Rep 8:6431. https:\/\/doi.org\/10.1038\/s41598-018-24741-0","journal-title":"Sci Rep"},{"key":"5130_CR53","doi-asserted-by":"publisher","first-page":"25346","DOI":"10.1038\/s41598-024-75652-2","volume":"14","author":"Y Liang","year":"2024","unstructured":"Liang Y, Yang X, Jin J et al (2024) Dietary selenium intake, hypertension and cognitive function among US adults, NHANES 2011\u20132014. Sci Rep 14:25346. https:\/\/doi.org\/10.1038\/s41598-024-75652-2","journal-title":"Sci Rep"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05130-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-05130-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05130-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T19:02:16Z","timestamp":1757790136000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-05130-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,19]]},"references-count":53,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["5130"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-05130-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.01.09.632229","asserted-by":"object"}]},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,19]]},"assertion":[{"value":"26 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author would like to inform that he filed a patent on \u201cSynaptosomal miRNAs and Synapse Functions in Alzheimer\u2019s Disease\u201d TTU Ref. No. 2022\u2013016, U.S. Patent App. No. PCT\/US2023\/019298 on Oct 26, 2023, related to the contents of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}